L'Oreal USA recalls La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL.…
Chemical Contamination: This recall has been initiated due to detected trace levels of benzene.
Read the official notice →- Date
- 2025-05-21
- Country
- United States
- Brand
- L'Oreal
- Product
- La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, 40 mL (135 FL.…
- Classification
- Class II
- Units
- Nationwide in the USA
- Category
- Drugs & medical
- Source
- FDA · Drug
Copied automatically from the US Food and Drug Administration. Details may be shortened or out of date; the official notice is the authoritative source. Disclaimer
What to do
- Check the product name, strength and lot number against the official notice.
- Do not stop a prescribed medicine without talking to your doctor or pharmacist first.
- Ask the pharmacy or supplier about a replacement or refund.
General guidance from Recall Atlas. The official notice from the US Food and Drug Administration has the exact models, batch codes and remedy, and it takes priority.
More L'Oreal recalls
- 2026-02-06
IT
EU
Hair dye (L'OREAL) · Excellence creme
According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, harm the health of the unborn…
- 2025-05-21
US
L'Oreal USA recalls La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, a) UPC…
cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay…
- 2025-04-11
IT
EU
Hair gel (L'OREAL) · 3 Force - Sculpte
According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the…
IT
EU
Hairspray (L'OREAL) · Infinium
According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the…
IT
EU
Hair cream (L'OREAL) · Steam pood
According to the list of ingredients, the product contains 2-(4-tert- butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the…
- 2025-01-31
IT
EU
Hair gel (L'OREAL) · FIX & FORCE
According to the list of ingredients, the product contains 2-(4-tert-butylbenzyl) propionaldehyde (BMHCA), which is prohibited in cosmetic products. BMHCA may harm the reproductive system, may harm the health of the…
Other drugs & medical recalls in the United States
- 2025-05-21
US
Vyaire Medical recalls Brand Name: AirLife Product Name: AirLife Infant Heated Wire Circuit Model/Catalog Number: AH165 Software Version: N/A Product…
Adapters may disconnect during setup or while in use, potentially interrupting ventilation. Any disconnection can result in severe consequences for neonates, including hypoxia, hypercapnia, and organ failure.
FDA · DeviceVyaire MedicalWorldwide distribution - US Nationwide and the countries of Germany, Poland,…Official notice →US
US
L'Oreal USA recalls La Roche-Posay Laboratoire Dermatologique Effaclar Duo Dual Action Acne Treatment, 5.5% Benzoyl Peroxide Acne Medication, a) UPC…
cGMP Deviations: The recall was initiated due to detected trace levels of benzene in a specific lot of this product lot (MYX46W), however out of an abundance of caution, the firm voluntarily recalled all La Roche-Posay…
- 2025-05-14
US
Philips Medical Systems Nederland B.V. recalls IntelliSpace Cardiovascular software versions 6.x, 7.x, and 8.x; Model Number: 830089.
An issue was identified with the software when using the Echo Module of ISCV, the issue may result in missing or incomplete information in the report.
FDA · DevicePhilips Medical Systems Nederland B.V.Domestic: Nationwide Distribution International: Australia, Austria, Belgium,…Official notice →US
WANDERCRAFT SAS recalls Atalante X, Powered Exoskeleton. Atalante X is intended to perform ambulatory functions and mobility exercises, hands-free, in…
Potential for exoskeleton to lose lateral balance and cause patient to fall.
US
Tornier S.A.S. recalls Blueprint Software, BPUE001. Intended for use by surgeons as a pre surgical planner for shoulder replacement.
A software bug in Blueprint version 4.2.1 prevents users from accessing cases initiated in previous versions of the software.
FDA · DeviceTornier S.A.S.Blueprint Version 4.2.1 is only currently available in the US. Domestic…Official notice →